utrogestan
utrogestan is a pharmaceutical drug with 7 clinical trials. Historical success rate of 50.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
50.0%
1 of 2 finished
50.0%
1 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparison of Pregnancy Rates in Modified Natural Frozen Embryo Transfer (FET) Cycle After Luteal Support with GnRH Agonist Versus Progesterone
Progesterone and Resting Energy Expenditure
Vaginal Versus Combined Use of Progesterone in Fresh IVF/ICSI Cycles
Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders
Endometrial Heparin-binding Epidermal Growth Factor Expression
Clinical Trials (7)
Comparison of Pregnancy Rates in Modified Natural Frozen Embryo Transfer (FET) Cycle After Luteal Support with GnRH Agonist Versus Progesterone
Progesterone and Resting Energy Expenditure
Vaginal Versus Combined Use of Progesterone in Fresh IVF/ICSI Cycles
Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders
Endometrial Heparin-binding Epidermal Growth Factor Expression
Implantation Enhancement by Elective Cryopreservation of All Viable Embryos
Utrogestan Versus Nifedipine as Tocolysis for Preterm Labor: a Randomised Controlled Trial
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7